Review links immune cells' energy use to MS inflammation

Review links immune cells' energy use to MS inflammation
Credibility
Interest
Share:1 min read
Key Takeaway

A review links changes in how immune cells use energy to inflammation in MS and other autoimmune diseases.

What They Found

The review describes how changes in immune cells' energy use may help drive inflammation in MS. It also covers rheumatoid arthritis and type 1 diabetes. Changes in how these cells use sugar and fat may affect how they respond. The authors describe similar changes in lupus, another disease in which the immune system attacks the body. They suggest these changes as possible treatment targets, but this review did not test a treatment.

Who Should Care and Why

This review covers research on immune cells in MS and several other autoimmune diseases. It does not focus on one form of MS. People with MS may be interested because the review examines how immune cells may contribute to inflammation. It also discusses research on rheumatoid arthritis, type 1 diabetes, and lupus. The authors note that treatments aimed at these cell changes could affect other parts of the body.

Important Considerations

This review does not report a number of study participants. It brings together existing research rather than testing a treatment. It does not show whether changing how immune cells use energy helps people with MS.

AI-generated summary — for informational purposes only, not medical advice

Categories:
Early Research
Article Topics:
AutoimmunityB cellsImmunometabolismT cells

You May Also Like

Childhood MS blood patterns linked to Epstein-Barr virus
Childhood MS blood patterns linked to Epstein-Barr virus

11/1/2026

Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN

Read More
Stem Cell Treatment May Calm MS Brain Inflammation
Stem Cell Treatment May Calm MS Brain Inflammation

11/1/2026

In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for

Read More
New Brain Scans May Reveal Hidden Inflammation in MS
New Brain Scans May Reveal Hidden Inflammation in MS

11/1/2026

A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method

Read More
Could Red Blood Cells Help Calm MS Immune Attacks?
Could Red Blood Cells Help Calm MS Immune Attacks?

10/9/2026

A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel

Read More
A Rare MS-Like Illness Offers Clues About Immune Care
A Rare MS-Like Illness Offers Clues About Immune Care

10/8/2026

A rare MS-like illness in one man may point to an immune system problem. Learn what this early findi

Read More
Sudden Vision Loss: An MS Look-Alike Worth Knowing
Sudden Vision Loss: An MS Look-Alike Worth Knowing

10/8/2026

A teen recovered from sudden vision loss caused by an MS look-alike. Learn why urgent care and the r

Read More
Understanding MS Research

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Cellular & molecular immunology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.